These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 20737745)
1. Opening and continuing the discussion on influenza vaccination timing. Ryan KJ; Rousculp MD Am J Manag Care; 2010 Aug; 16(8):628-9; author reply 629-30. PubMed ID: 20737745 [No Abstract] [Full Text] [Related]
2. [Cost-effectiveness of prophylaxis and treatment of influenza]. Rychlik R; Heinen-Kammerer T; Rusche H; Piercy J; Scuffham P; Zöllner Y Dtsch Med Wochenschr; 2003 Oct; 128(43):2267-70. PubMed ID: 14574642 [No Abstract] [Full Text] [Related]
3. Preventing influenza--the case for immunizing children at school. School Nurse News; 2008 Nov; 25(5):9. PubMed ID: 19146061 [No Abstract] [Full Text] [Related]
4. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851 [TBL] [Abstract][Full Text] [Related]
5. Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years. Prosser LA; Meltzer MI; Fiore A; Epperson S; Bridges CB; Hinrichsen V; Lieu TA Arch Pediatr Adolesc Med; 2011 Feb; 165(2):112-8. PubMed ID: 20921341 [TBL] [Abstract][Full Text] [Related]
7. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis. Rothberg MB; Rose DN Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212 [TBL] [Abstract][Full Text] [Related]
9. Medical economics in the field of influenza--past, present and future. Szucs TD Virus Res; 2004 Jul; 103(1-2):25-30. PubMed ID: 15163484 [TBL] [Abstract][Full Text] [Related]
10. The economic implications of influenza vaccination for adults with asthma. Trogdon JG; Nurmagambetov TA; Thompson HF Am J Prev Med; 2010 Nov; 39(5):403-10. PubMed ID: 20965377 [TBL] [Abstract][Full Text] [Related]
11. The effectiveness of vaccination against influenza in healthy, working adults. Nichol KL; Lind A; Margolis KL; Murdoch M; McFadden R; Hauge M; Magnan S; Drake M N Engl J Med; 1995 Oct; 333(14):889-93. PubMed ID: 7666874 [TBL] [Abstract][Full Text] [Related]
12. [Pharmaco-economics of anti-influenza vaccinations]. Jahnz-Rózyk K Pol Merkur Lekarski; 2003 Jun; 14(84):679-81. PubMed ID: 14524303 [TBL] [Abstract][Full Text] [Related]
13. Population-wide benefits of routine vaccination of children against influenza. Weycker D; Edelsberg J; Halloran ME; Longini IM; Nizam A; Ciuryla V; Oster G Vaccine; 2005 Jan; 23(10):1284-93. PubMed ID: 15652671 [TBL] [Abstract][Full Text] [Related]
14. [Economic prerequisites of active influenza prevention]. Grześk G; Gałaj A; Korbal P; Durmowicz A; Szadujkis-Szadurski L; Borys D; Grześk E Med Pr; 2002; 53(4):329-32. PubMed ID: 12474413 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of influenza vaccination of healthy children. Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945 [TBL] [Abstract][Full Text] [Related]
17. Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial. Schmier J; Li S; King JC; Nichol K; Mahadevia PJ Health Aff (Millwood); 2008; 27(2):w96-104. PubMed ID: 18216044 [TBL] [Abstract][Full Text] [Related]